On November 15, more than 125 physicians and other healthcare professionals from Main Line Health and the Philadelphia area participated in a symposium/case-based Continuing Medical Education (CME) activity, “Venous Thromboembolism-The Difficult Questions,” sponsored by Main Line Health and the Annenberg Center, with support from the Laennec Society.
“The prestigious, world-renowned medical faculty that this conference attracted enhances Lankenau’s position as a leader in the medical community, both locally and across the country,” said David Cohen, MD, FACP, symposium director, Lankenau Medical Center, who led the discussions. “We are honored to host these symposiums and to provide medical professionals with the opportunity to learn about new advancements in medicine in a forum that allows for discussion and patient case review.”
The symposium, held at Lankenau Medical Center, featured world-renowned medical faculty. Attending the symposium were (from left): Lee Greenspon, MD, LMC pulmonologist and member of the symposium’s Planning Committee; Michael Streiff, MD, John Hopkins Medical Center; Charles Francis, MD, University of Rochester; Victor Tapson, MD, Duke University Medical Center; Dr. Cohen; Jeffrey Olin, DO, Mt. Sinai School of Medicine; Samuel Goldhaber, MD, Harvard Medical School; and Joshua Danley, DO, LMC pulmonology fellow and member of the symposium’s Planning Committee.
Lankenau Medical Center, a member of Main Line Health, is recognized as a national leader in advancing new options to diagnose and treat illness, protect against disease and save lives. Located on a 93-acre suburban campus just outside of Philadelphia, Lankenau Medical Center is a 389-bed, not-for-profit teaching hospital that includes one of the nation’s leading cardiovascular centers; the Lankenau Institute of Medical Research, one of the few freestanding hospital-associated research centers in the nation; and the Annenberg Conference Center for Medical Education. Lankenau offers state-of-the-art services from cancer care to maternity care. Lankenau is ranked as number six in Pennsylvania and number four in the Philadelphia metro area in U.S. News & World Report’s Best Hospitals. Lankenau Medical Center is also ranked nationally for diabetes and endocrinology, and is high-performing in eight specialties: cardiology & heart surgery, diabetes & endocrinology, gastroenterology & GI surgery, geriatrics, neurology & neurosurgery, orthopedics, pulmonology and urology. Lankenau has achieved The Joint Commission’s Gold Seal of Approval for stroke care and breast cancer care and is one of the nation’s Top Performing Hospitals for heart attack, heart failure, pneumonia and surgical care. Lankenau has also been ranked for multiple years as one of the top 50 cardiovascular hospitals in the nation by Truven Health Analytics. Lankenau has earned Magnet® designation for the third time for its superior nursing staff.
© 2016 Main Line Health